Hualu Biotech (300970.SZ): A total cost of 30.46 million yuan to repurchase 2,346,600 shares

Gelonghui, May 31, 丨 Hualu Biotech (300970.SZ) announced that as of May 31, 2024, the company was repurchasing 2,346,600 shares through the Shenzhen Stock Exchange stock trading system, accounting for 1.99% of the company's current total share capital. The highest transaction price was 13.83 yuan/share, the minimum transaction price was 12.22 yuan/share, and the total transaction amount was RMB 30.46 million (excluding transaction fees).

Gelonghui FinanceMay 31 05:21 ET

Hualu Biotech (300970.SZ) 2023 equity distribution: 2 yuan for every 10 shares

According to Zhitong Finance App, Hualu Biotech (300970.SZ) announced that the company's 2023 equity distribution plan is to distribute 2 yuan in cash (tax included) to all shareholders for every 10 shares. The share registration date for this equity distribution is: June 3, 2024, and the ex-dividend date is June 4, 2024.

Zhitong FinanceMay 27 07:07 ET

Hualu Biotech (300970.SZ): Not involved in artificial meat business

Gelonghui, May 13 | Hualu Biotech (300970.SZ) said on the investor interactive platform that the company is not involved in the artificial meat business yet.

Gelonghui FinanceMay 13 03:19 ET

Hualu Biotech (300970.SZ): 1.99% of shares have been repurchased

Gelonghui, April 30, 丨 Hualu Biotech (300970.SZ) announced that as of April 30, 2024, the company will repurchase 2,346,600 shares of the company through centralized bidding transactions through the Shenzhen Stock Exchange stock trading system, accounting for 1.99% of the company's current total share capital. The maximum transaction price is 13.83 yuan/share, the minimum transaction price is 12.22 yuan/share, and the total transaction amount is RMB 30.46 million (excluding transaction fees).

Gelonghui FinanceApr 30 04:49 ET

Hualu Biotech (300970.SZ): Net profit of 1,7395 million yuan in the first quarter decreased by 98.66% year-on-year

Gelonghui, April 22 | Hualu Biotech (300970.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 257 million yuan, down 22.75% year on year; net profit attributable to shareholders of listed companies was 1,7395 million yuan, down 98.66% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 817,700 yuan, down 99.36% year on year; basic earnings per share were 0.02 yuan.

Gelonghui FinanceApr 22 09:39 ET

Hualu Biotech (300970.SZ) will list and circulate 48,135,500 restricted shares on April 19

Zhitong Finance App News, Hualu Biotech (300970.SZ) announced that the number of shares issued by the company before the initial public offering has been lifted is 48.135,500 shares, accounting for 40.8313% of the company's total share capital. The listing circulation date is April 19, 2024 (Friday).

Zhitong FinanceApr 16 04:51 ET